Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Actividad Física Virtual Ejercicio Sentado - Fase 2 (V-PASE)

18 de septiembre de 2026 actualizado por: Janice Eng, University of British Columbia

Assessing a Telehealth Seated Exercise Program on Post-stroke Balance and Mobility: A Mixed-method Design

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.

Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Descripción general del estudio

Descripción detallada

The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor.

Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

100

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • British Columbia
      • Vancouver, British Columbia, Canadá, V5Z 2G9
        • GF Strong Rehabilitation Centre
    • Manitoba
      • Winnipeg, Manitoba, Canadá
        • University of Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Canadá
        • Nova Scotia Health
    • Ontario
      • London, Ontario, Canadá
        • Western University
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canadá
        • University of Saskatchewan

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Participants must meet the following inclusion criteria:

  • Adult (as defined by Province)
  • Chronic stroke (more than 6 months post-stroke)
  • Ability to stand up from a chair
  • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
  • Able to safely engage in exercise and tolerate 60 minutes of exercises
  • Able to communicate in English
  • Have access to a tablet, computer, or laptop with internet and email access

Exclusion Criteria:

Participants will be excluded if they meet any of the following criteria:

  • Participating in formal exercise or rehabilitation activities
  • Participating in > 30 minutes/day of physical activity (moderate intensity)
  • Participating in another study that may affect outcomes to this study
  • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
  • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
  • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: 10-week group

Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration.

The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

Sin intervención: Delayed 2-week group (Boot Camp)

The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
30 Second Sit-to-Stand
Periodo de tiempo: Immediately post-intervention (following 10-week trial)

Assessment of balance and lower extremity strength.

Immediately post-intervention (following 10-week trial)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Timed Up and Go
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

Participants stand up from a chair, walk 3 metres, turn around and then sit back down. The TUG assesses balance, mobility and turning ability

Immediately post-intervention, and retention (2-months post-intervention)
Tandem Stance
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

Measures balance in standing as reported in the Short Physical Performance Battery Protocol

Immediately post-intervention, and retention (2-months post-intervention)
Modified Telehealth Fugl-Meyer
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

The modified virtual Fugl-Meyer assess lower extremity impairments in those with stroke

Immediately post-intervention, and retention (2-months post-intervention)
Stroke Impact Scale
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

A self-reported measure of stroke-related disability. There are 8 domains with each item rated using a 5-point Likert scale, where lower scores mean greater difficulty to complete the item.

Immediately post-intervention, and retention (2-months post-intervention)
Activities-Specific Balance Confidence (ABC)
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

The ABC scale is a 16-item questionnaire where a participant rates their confidence in performing activities from 0% to 100% (higher percentages indicate greater self-efficacy).

Immediately post-intervention, and retention (2-months post-intervention)
Fatigue Severity Scale
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

Questionnaire assessing the impact of fatigue on daily tasks and activities. There are 9 questions, each scored from 1 to 7 (1 = strongly disagree; 7 = strong agreement).

Immediately post-intervention, and retention (2-months post-intervention)
Quality of Life (EQ-5D-5L)
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

The EQ-5D-5L assess self-care, mobility, depression/anxiety, pain, and usual activities. Each is scored with 5 levels (1=no problems, 5=major problems). Overall health on the day is scored from 0% (worst health) to 100% (best health).

Immediately post-intervention, and retention (2-months post-intervention)
Patient Health Questionnaire-4 (PHQ-4)
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

The PHQ-4 focuses on depression and anxiety. Questions are scored from 0 to 3 (0=not at all; 3 = Nearly every day).

Immediately post-intervention, and retention (2-months post-intervention)
Montreal Cognitive Assessment scale (MoCA-BLIND)
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

The MoCA-BLIND assess six different cognitive domains (excludes visual stimulus) over the phone: memory, attention, language, abstraction, delayed recall, and orientation. The MoCA-BLIND is scored from 0-22 (22 = no cognitive impairments).

Immediately post-intervention, and retention (2-months post-intervention)
Lipid Profiles
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Fasting Glucose
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Glucose (HbA1c)
Periodo de tiempo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
30 Second Sit-to-Stand
Periodo de tiempo: Retention (2-months post-intervention)

Assessment of balance and lower extremity strength.

Retention (2-months post-intervention)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Feasibility Indicator: Compliance
Periodo de tiempo: Through study completion (approximately 10 weeks)

Percentage of participants that attend exercise sessions.

Through study completion (approximately 10 weeks)
Feasibility Indicator: Safety
Periodo de tiempo: Through study completion (approximately 10 weeks)

Number of adverse events that occur during assessments or exercise sessions.

Through study completion (approximately 10 weeks)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

11 de octubre de 2023

Finalización primaria (Estimado)

31 de diciembre de 2026

Finalización del estudio (Estimado)

31 de marzo de 2027

Fechas de registro del estudio

Enviado por primera vez

17 de enero de 2023

Primero enviado que cumplió con los criterios de control de calidad

1 de febrero de 2023

Publicado por primera vez (Actual)

13 de febrero de 2023

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

23 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

18 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir